fda glp-1 safety warning september 2025 Safe use of compounded GLP products FDA Issues 30 Warning Letters

Second, heterogeneity in patient populations, including baseline metabolic status, age, sex, and genetic background, may affect hormonal dynamics and therapeutic outcomes

In 2023, she announced publicly that she had used GLP-1s to lose weight and spoke out about the misconception that medication is somehow a shortcut or easy way out

A veteran New York litigator is taking on opioid makers

"That's why it's so important to go through medical professionals." When it comes to weighing risks versus benefits, Debussy said, "It's patient specific

Exenatide extended-release has been shown in studies to cause thyroid tumors in animals, but it's not yet known if it can cause thyroid cancer in people